(Q33949952)

English

Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

author name string

Datla KP

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Blunt SB

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dexter DT

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 May 2001

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

424-434

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Neurotoxicity of levodopa on catecholamine-rich neurons

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Protective effect of carbidopa on hydroxyl radical generation in the rat striatum by dopamine.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Differential effects of chronic L-dopa treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Nigrostriatal Dopaminergic Neurons Remain Undamaged in Rats Given High Doses of l-DOPA and Carbidopa Chronically

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year period.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Increased nigral iron content in postmortem parkinsonian brain

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Iron induces degeneration of nigrostriatal neurons

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

The effect ofl-DOPA and carbidopa treatment on the survival of rat fetal dopamine grafts assessed by tyrosine hydroxylase immunohistochemistry and [3H]mazindol autoradiography

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Effect of p-chlorophenylalanine at moderate dosage on 5-HT and 5-HIAA concentrations in brain regions of control and p-chloroamphetamine treated rats

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Dopaminergic stimulation up-regulates the in vivo expression of brain-derived neurotrophic factor (BDNF) in the striatum.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures

1 reference

https://api.crossref.org/works/10.1002%2FMDS.1091

21 January 2018

Identifiers

10.1002/MDS.1091

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33949952&oldid=2038915561"